Biopharma and Health Related News

Manus Bio awarded funding to develop novel production method for Artemisinin

CAMBRIDGE, Mass., Jan. 11, 2018 - Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received funding from the Bill & Melinda Gates Foundation for the development of a [...]

Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations

January 09, 2018 Advances development of Inovio’s ASPIRE™ (Antigen SPecific Immune REsponses) immunotherapy platform as a foundation for novel combination regimen approaches Engages the Parker Institute’s extensive immunotherapy expertise and academic and research network on studies that have the potential [...]

AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock

Wednesday, January 10, 2018 6:00 am EST - SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the pricing of a public offering of 4,000,000 [...]

Bell Biosystems, Inc. Announces Pre-Clinical Results of Major in Vivo Safety Study Milestone

PRESS RELEASE JAN 8, 2018 12:00 PST BERKELEY, Calif., January 8, 2018 ( - Bell Biosystems, Inc. (Bell) today presented the results of their latest pre-clinical safety study at the Biotech Showcase in San Francisco that runs concurrently with the annual [...]

We Scientists Need to Comment on the “Raw Water” Fad

The West Coast has been the breeding ground for many amazing cultural and tech trends of our time. Without a doubt, live water is not one of them. Live water, also known as raw water, is the term that has [...]

Adapsyn Bioscience Completes Financing to Advance its Small Molecule Natural Product Platform and Pipeline; Announces Research Collaboration with Pfizer Inc.

HAMILTON, ON, Jan. 9, 2018 /PRNewswire/ - Adapsyn Bioscience Inc., a biotechnology company focused on the discovery and development of novel medicines derived from evolved small molecule natural products, today announced that it has completed a round of financing that was [...]